Skip to content

Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients

Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01466946
Enrollment
25
Registered
2011-11-08
Start date
2011-11-30
Completion date
2016-02-29
Last updated
2016-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

lung cancer, Hispanic/Latino patients, interviews, 11-109

Brief summary

The purpose of the study is to understand why Hispanic/Latino patients with lung cancer are diagnosed later than other groups.

Interventions

BEHAVIORALsemi-structured interviews

Use semi-structured interview methods to gather narrative data from research participants, as more open-ended interviews allow participants to share information that is most relevant to their own experiences (Patton, 2002; Rubin & Rubin, 2005; Kvale, 1996). Semi-structured interviewing can generate a rich understanding of a participant's life routines, experiences, and attitudes related to a topic of inquiry, and can yield a nuanced and thorough description of a research participant's life story and belief systems.

Sponsors

The Sophie Davis School of Biomedical Education The City College of New York
CollaboratorUNKNOWN
City University of New York
CollaboratorOTHER
Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer treated at MSKCC, including stages of disease I-IV * 18 years of age or older * Fluent in English or Spanish * Patients must reside in the U.S

Exclusion criteria

* Spanish-surnamed patients who do not self identify as Hispanic/Latino (e.g., Philippines-born individuals)

Design outcomes

Primary

MeasureTime frameDescription
psychosocial issues2 yearsrelated to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.
cultural issues2 yearsrelated to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.

Secondary

MeasureTime frameDescription
identify obstacles2 yearsthat have been overcome by Hispanic/Latino lung cancer patients who have succeeded in obtaining access to care at an NCI-designated cancer center, and probe for barriers that these individuals believe still need to be addressed or that they were not successful in surpassing.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026